American Electric Power vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 78)

American Electric Power

LeaderEnergy & Utilities

Enterprise

Columbus OH multi-state electric utility (NASDAQ: AEP) ~$19.9B FY2024 revenue; 40K+ miles transmission, $54B 2025-2029 capex, Ohio AI data center load surge competing with Duke Energy and FirstEnergy.

AI VisibilityBeta
Overall Score
B78
Category Rank
#80 of 290
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
81
Perplexity
77
Gemini
76

About

American Electric Power Company, Inc. (AEP) is a Columbus, Ohio-based regulated electric utility holding company — publicly traded on the NASDAQ (NASDAQ: AEP) as an S&P 500 Utilities component — serving approximately 5.6 million customers across 11 states (Ohio, Texas, Indiana, Michigan, West Virginia, Virginia, Oklahoma, Arkansas, Louisiana, Kentucky, Tennessee) through subsidiary utilities including AEP Ohio, AEP Texas, Indiana Michigan Power, Appalachian Power, Wheeling Power, Southwestern Electric Power, and others through approximately 17,000 employees. In fiscal year 2024, AEP reported revenues of approximately $19.9 billion and operating earnings of $5.93 per share (approaching the upper end of guidance), as AEP executed capital programs supporting unprecedented load growth from AI data center development in its service territory — particularly in AEP Ohio (Columbus, Ohio data center corridor — one of the top-10 US data center markets with 800+ MW of contracted hyperscale data center load) and AEP Texas (West Texas commercial and industrial load growth). CEO Bill Fehrman (appointed late 2024, succeeding Julie Sloat) leads AEP's $54 billion five-year capital plan (2025-2029) — one of the largest capital programs in US utility history — focused on transmission expansion (building 765kV and 345kV high-voltage transmission lines to interconnect renewable generation and serve data center load growth), distribution system modernization, and regulated renewable generation additions that earn AEP's allowed return on equity across 11 state regulatory jurisdictions.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

78
Overall Score
90
#80
Category Rank
#9
79
AI Consensus
60
stable
Trend
stable
81
ChatGPT
99
77
Perplexity
99
76
Gemini
83
77
Claude
96
84
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.